Dashboard PDUFA PDUFA History Dilution Watch Downside Radar Missed Milestones Earnings Big Movers Blog

🎤 Upcoming Biotech Conferences

Loading conferences...
Free to browse, no account needed Follow the companies behind these drugs with free AI briefings, catalyst countdowns and dilution alerts.
Start 7-day free trial → Log in

Carbamazepine · Tegretol, G-32883

Small molecule · developed by Novartis

Approved FDA, Mar 1968
1 Registered trials

What is Carbamazepine?

Carbamazepine is a small molecule with anticonvulsant and analgesic properties. It is used in the treatment of epilepsy and the pain of trigeminal neuralgia.

Summary written with AI from the sources listed at the end of this page.

At a glance

Also known as
Tegretol, G-32883, GEIGY 32883, NSC-169864
Drug type
Small molecule
Therapy area
Neurology
Developer
Novartis
In trials of
AVIR
FDA status
Approved as Tegretol (March 11, 1968), NDA016608 · FDA label
UNII
33CM23913M

✅ FDA-approved uses

From the indications section of the FDA label (version of Aug 20, 2026). Read the full label for the exact wording, limitations and safety information.

🧪 Clinical trials

TrialPhaseConditionStatusSponsor
NCT04784000 Phase 1 Healthy Volunteer Study Completed AVIR

Trials of the companies BioRadar tracks, from ClinicalTrials.gov, most advanced phase first.

Conditions studied

Healthy Volunteer Study

Sources

Updated Oct 11, 2026.

Data: FDA (Drugs@FDA, Purple Book, DailyMed), NIH (NCI Thesaurus, GSRS, RxNorm), ClinicalTrials.gov • Informational purposes only, not medical or investment advice. • All drugs A–Z

This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.